A detailed history of Apella Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Apella Capital, LLC holds 23,987 shares of JNJ stock, worth $3.84 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
23,987
Previous 23,235 3.24%
Holding current value
$3.84 Million
Previous $3.4 Million 14.46%
% of portfolio
0.16%
Previous 0.16%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$145.48 - $167.38 $109,400 - $125,869
752 Added 3.24%
23,987 $3.89 Million
Q2 2024

Jul 10, 2024

BUY
$144.38 - $157.78 $556,584 - $608,241
3,855 Added 19.89%
23,235 $3.4 Million
Q1 2024

Apr 10, 2024

SELL
$155.22 - $162.74 $12,883 - $13,507
-83 Reduced 0.43%
19,380 $3.07 Million
Q4 2023

Jan 05, 2024

BUY
$145.6 - $158.88 $897,478 - $979,336
6,164 Added 46.35%
19,463 $3.05 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $32,396 - $36,291
-208 Reduced 1.54%
13,299 $2.07 Million
Q2 2023

Jul 06, 2023

BUY
$154.35 - $166.11 $70,692 - $76,078
458 Added 3.51%
13,507 $2.24 Million
Q4 2022

Jan 10, 2023

BUY
$160.2 - $179.79 $604,594 - $678,527
3,774 Added 40.69%
13,049 $0
Q3 2022

Oct 11, 2022

SELL
$161.33 - $179.52 $123,901 - $137,871
-768 Reduced 7.65%
9,275 $1.52 Million
Q2 2022

Jul 08, 2022

BUY
$168.19 - $186.01 $230,588 - $255,019
1,371 Added 15.81%
10,043 $1.78 Million
Q1 2022

Apr 11, 2022

BUY
$158.14 - $179.59 $41,116 - $46,693
260 Added 3.09%
8,672 $1.54 Million
Q4 2021

Jan 13, 2022

BUY
$155.93 - $173.01 $189,610 - $210,380
1,216 Added 16.9%
8,412 $1.44 Million
Q3 2021

Jan 18, 2022

SELL
$161.5 - $179.47 $88,017 - $97,811
-545 Reduced 7.04%
7,196 $1.16 Million
Q3 2021

Oct 12, 2021

SELL
$161.5 - $179.47 $55,071 - $61,199
-341 Reduced 4.22%
7,741 $1.24 Million
Q2 2021

Jan 18, 2022

SELL
$159.48 - $171.07 $88,351 - $94,772
-554 Reduced 6.42%
8,082 $1.33 Million
Q2 2021

Jul 02, 2021

SELL
$159.48 - $171.07 $1,913 - $2,052
-12 Reduced 0.14%
8,636 $1.42 Million
Q1 2021

Apr 15, 2021

BUY
$153.07 - $170.48 $18,674 - $20,798
122 Added 1.43%
8,648 $1.42 Million
Q4 2020

Feb 18, 2021

SELL
$137.11 - $157.38 $86,379 - $99,149
-630 Reduced 6.88%
8,526 $1.34 Million
Q3 2020

Oct 22, 2020

BUY
$140.38 - $153.83 $6,878 - $7,537
49 Added 0.54%
9,156 $1.36 Million
Q2 2020

Jul 20, 2020

BUY
$128.81 - $155.51 $12,881 - $15,551
100 Added 1.11%
9,107 $1.28 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $1 Million - $1.39 Million
9,007 New
9,007 $1.18 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Apella Capital, LLC Portfolio

Follow Apella Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.